Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delafloxacin in Surgical Site Infections (DRESS)
NCT04042077Phase 3Terminated
- Sponsor
- Menarini Group
- Start
- Sep 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of delafloxacin in surgical site infection (SSI) (2 arms), sponsored by Menarini Group. Primary endpoint: Clinical Success at Test of Cure Visit. Started Sep 2019; status: terminated.
02
Drugs
delafloxacin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04042077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042077.